glp 1 agonist risks Do The Benefits of GLP-1 Drugs OutWeigh the Negatives? glp 1 agonist risks GLP-1

Macro vascular complications are still the primary cause of death in patients with T2DM.Glucagon like peptide-1 receptor agonists (GLP1-RAs) are a new class of Injectable Anti-diabetes Agents (IADA) that provides blood glucose control with weight reduction ability, systolic blood pressure reduction and a noticeable improvement of lipid profile

However, many patients have been found to have residual gastric contents after fasting, even when on stable doses

While Li et al

Zepbound Compounded GLP-1 injections: availability varies Oral options: compounded GLP-1 kits Wellness add-ons: shakes

Standard chow (CE-2, CLEA japan) and water were available ad libitum

Diabetes (2018) 67